跳至主要内容
临床试验/CTRI/2020/02/023137
CTRI/2020/02/023137尚未招募未知

Clinical Study To Evaluate Efficacy Of Haritakyadi Kwath In Madhumeha With Special Reference To Type II Diabetes Mellitus.

Hon Shri Annasaheb Dange Ayurvedic Medical College Ashta Sangli0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Willing to give consent to participate in the study.
  • 2.Type of Disease-Apathyanimittaja Prameha (Diabetes Mellitus type2 NIDDM).
  • 3.Fasting Blood sugar range- 126 to 250 mg/dl.
  • 4.Post Prandial Blood sugar range-200 to 325 mg/dl

排除标准

  • 1.Patient not willing to participate in the study or not in position to give consent.
  • 2.Patients of IDDM (Insulin Dependent Diabetes Mellitus)(DM Type 1).
  • 3.Patients below 25 years of age & above 70 years of age.
  • 4.Patients with Blood Sugar Level â?? FBS > 250 mg/dl PPBS > 325 mg/dl.
  • 5.Patients with Gestational Diabetes.
  • 6.Patients with severe complications (Chronic)[Micro & Macro-Vascular complications]
  • 7.Patients in whom DM is caused due to Endocrinopathies like: -
  • a) Acromegaly
  • b) Cushingâ??s Syndrome
  • c)Glucagonoma
  • d)Pheochromocytoma
  • e)Hyperthyroidism.
  • 8. Patients in whom DM is caused as a drug induced complications .
  • Ex:- a) Steroids
  • b) Thiazide like Diuretics
  • c) Nicotinic Acid
  • d) Protease Inhibitors
  • e) Beta Blockers
  • 9.Patients suffering from any serious systemic disorders.
  • 10.Patients with DKA (Diabetic Ketoacidosis), Lactic acidosis

研究者

发起方
Hon Shri Annasaheb Dange Ayurvedic Medical College Ashta Sangli

相似试验